Credit Suisse Ag Volitionrx LTD Transaction History

Credit Suisse Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.02 - $4.13 $89,207 - $121,996	-29,539 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.98 - $3.48 $6,722 - $7,850	-2,256 Reduced 7.1%	29,539 $92,000
Q2 2021 Aug 16, 2021	BUY	$3.01 - $3.78 $95,702 - $120,185	31,795 New	31,795 $104,000
Q3 2019 Nov 12, 2019	SELL	$2.97 - $6.42 $109,890 - $237,540	-37,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.93 - $3.6 $82,040 - $100,800	-28,000 Reduced 43.08%	37,000 $116,000
Q1 2019 May 14, 2019	SELL	$2.19 - $3.45 $2 - $3	-1 Reduced -0.0%	65,000 $211,000
Q4 2018 Feb 13, 2019	SELL	$1.7 - $2.88 $3 - $5	-2 Reduced -0.0%	65,001 $118,000
Q2 2018 Aug 14, 2018	BUY	$1.88 - $2.41 $5 - $7	3 Added 0.0%	65,003 $130,000
Q1 2018 May 15, 2018	BUY	$2.29 - $3.95 $148,850 - $256,750	65,000 New	65,000 $156,000

8.17M

53.6K

300

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $33.2M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.